The topmost ranked genes uncovered for the PD doublets include CDCA3, PLK1, NEK2 and FAM64A (Table 1), which are involved in ovarian cancer cell proliferation and drug resistance33–36. This evidence concerns the gene PLK1 and ovarian carcinoma.